Decrease in PNH-type Blood Cells after the Cessation of Thrombopoietin Receptor Agonist in a Case of AA-PNH Syndrome.

Intern MedMar 17, 2026 (epub)
Case ReportHematology

Satoshi Ichikawa, Shunsuke Hatta, Noriko Fukuhara et al.

✦ AI-curated · Sources linked

Case in brief

A 64-year-old man with severe aplastic anemia had a partial response to immunosuppressive therapy, followed by sustained cytopenia recovery with a thrombopoietin receptor agonist (TPO-RA). Over subsequent years, serum lactate dehydrogenase gradually rose, and testing showed marked expansion of paroxysmal nocturnal hemoglobinuria (PNH) clones. After a transient hemolytic episode associated with SARS-CoV-2 infection, TPO-RA was stopped. Follow-up showed fewer PNH clones. Blood counts declined moderately but remained stable without transfusion support.

What made this case unusual

PNH clones decreased after TPO-RA withdrawal, despite the preceding marked expansion during treatment; the patient’s blood counts remained stable without transfusions.

Diagnostic / clinical pearl

In a patient with aplastic anemia receiving TPO-RA, rising lactate dehydrogenase and expanding PNH clones may warrant attention to clonal evolution and hemolysis; this case also documents clone reduction after treatment cessation.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Hematology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.